Purpose: Suspected serious disease (SSD) is a disease designation often given to patients with one or more non-specific symptoms of severe disease that could be due to cancer; the optimal diagnostic strategy is largely left to the clinician's discretion. Being a sensitive non-invasive whole-body imaging modality 18 F-FDG-PET/CT may have a potential role in this cancer-prevalent group of patients to confirm or refute suspected malignancy. We aimed to investigate the diagnostic value of 18 F-FDG-PET/CT in SSD using long-term follow-up as reference. Methods: We retrospectively studied results obtained in all SSD patients referred for 18 F-FDG-PET/CT at a single institution in 2010-2011 retrieving the following clinical data in all patients: journal entries, examinations, and evaluations made from six months before the scan and until the latest recorded entry. A true positive PET scan was a positive scan with a subsequently biopsyconfirmed diagnosis of cancer in the same target organ, whereas a false positive scan had no subsequent cancer diagnosis. A true negative PET scan was a negative scan without a cancer diagnosis during follow-up, whereas a false negative PET scan was one with a subsequently confirmed cancer diagnosis. Results: Ninety-three patients, aged 67 years (range 25-89) were included and followed for up to 7.3 years (median 6). Of these, 21 (22.6% [95% CI: 15.3-32.1]) turned out to have cancer. With 18 F-FDG-PET/CT, the sensitivity was 81.0% (95% CI: 60.0-92.3), specificity 76.4% (95% CI: 65.4-84.7), positive predictive value 50% (95% CI: 34.1-65.9), and negative predictive value 93.2% (95% CI: 83.8-97.3). Five patients with negative scans were subsequently diagnosed with cancer. Conclusion: Cancer prevalence is substantial among patients with SSD. 18 F-FDG-PET/CT is a promising option in this setting, in particular because a high negative predictive value equals a low incidence of cancer during follow-up. Further studies are needed to establish the role of 18 F-FDG-PET/CT in SSD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.